TY - JOUR
T1 - Increased serum thyroglobulin levels and negative imaging in thyroid cancer patients
T2 - Are there sources of benign secretion? A speculative short review
AU - Zanotti-Fregonara, Paolo
AU - Keller, Isabelle
AU - Calzada-Nocaudie, Marie
AU - Al-Nahhas, Adil
AU - Devaux, Jean Yves
AU - Grassetto, Gaia
AU - Marzola, Maria Cristina
AU - Rubello, Domenico
AU - Hindié, Elif
PY - 2010/12/1
Y1 - 2010/12/1
N2 - After thyroidectomy and 131I ablation for differentiated thyroid cancer (DTC), serum thyroglobulin (Tg) became a sensitive marker of residual disease. It is not uncommon to find patients at follow-up with persistent serum Tg levels and no other clinical or imaging evidence for the disease. The vast majority of these patients, most probably, have occult foci of disease, often in minute cervical lymph nodes. A review of the literature including papers published on PubMed/Medline until June 2010 was made. In this study we speculated that a minority of patients who had undergone surgery for differentiated thyroid cancer might have benign sources of Tg secretion at follow-up. These sources may be foci of radio-resistant ectopic thyroid tissue or a thyroid stimulating hormone-stimulated thymus.
AB - After thyroidectomy and 131I ablation for differentiated thyroid cancer (DTC), serum thyroglobulin (Tg) became a sensitive marker of residual disease. It is not uncommon to find patients at follow-up with persistent serum Tg levels and no other clinical or imaging evidence for the disease. The vast majority of these patients, most probably, have occult foci of disease, often in minute cervical lymph nodes. A review of the literature including papers published on PubMed/Medline until June 2010 was made. In this study we speculated that a minority of patients who had undergone surgery for differentiated thyroid cancer might have benign sources of Tg secretion at follow-up. These sources may be foci of radio-resistant ectopic thyroid tissue or a thyroid stimulating hormone-stimulated thymus.
KW - benign sources of thyroglobulin production
KW - differentiated thyroid cancer
KW - follow-up
KW - serum thyroglobulin levels
UR - http://www.scopus.com/inward/record.url?scp=78649270339&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=78649270339&partnerID=8YFLogxK
U2 - 10.1097/MNM.0b013e328340e717
DO - 10.1097/MNM.0b013e328340e717
M3 - Review article
C2 - 21088504
AN - SCOPUS:78649270339
VL - 31
SP - 1054
EP - 1058
JO - Nuclear medicine communications
JF - Nuclear medicine communications
SN - 0143-3636
IS - 12
ER -